Skip to main content
FDA approves pirtobrutinib for r/r mantle cell lymphoma
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves pirtobrutinib for r/r mantle cell lymphoma
User login
Username
Password
Reset your password
Concept
Lead
score
Mantle Cell Lymphoma
1
1
Tyrosine Kinase Inhibitor
0
0.68
Biologic Therapy
0
0.59
Tyrosine Kinase
0
0.55
Lymphoma
0
0.48
Refractory
0
0.48
Grant
0
0.14
Toxicology
0
0.14
Platelet Count
0
0.12
Atrial Fibrillation
0
0.09
Diarrhea
0
0.09
Pain Management
0
0.09
Pneumonia
0
0.09
Cancer
0
0.07
Dyspnea
0
0.07
Edema
0
0.07
Fatigue
0
0.07
Hemorrhage
0
0.07
Lymphocytes
0
0.07
Neutrophils
0
0.07
Orphan Drugs
0
0.07
Pain
0
0.07
Prognosis
0
0.07
Texas
0
0.07
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.9
Edit Tags